Petro Matad funded for its drilling programme which should see production start next year. Watch the full video here.
That is one reason why I put it down as the lesser of the 2 reasons and totally accept what you say about the different types and environment for recruiting of trial patients.
However I do believe that SCLP is held back a little by its track record of seeming to struggle to reach FPI. I quoted the Combo trial as being an example of this and don’t forget it is 6 years since that trial was first mooted and at least 9 months before the Pandemic when we were told it was starting.
Anyway the important point is to reach FPI as quickly as possible
Agree with some others that FPI will be an inflection point in the SP.
The major inflection point will be in the data but I would not underestimate FPI due to considerations.
1. The major one being it confirms everything is ready for trial commencement so Product,delivery mechanism etc.
2. Given the history of SCLP in announcing initiation of trials but not announcing FPI as in SCIB 1/Combo then I do believe it will represent a major step forward.
Like this quote
Scientists at Nottingham University and the UK company Scancell are developing a universal Covid-19 vaccine which, as well as the surface spikes, targets a protein in the core of the virus which is far less likely to mutate.
Human trials are expected to start this year after positive results on mice showed the formula can induce an immune response.
Plus invite from CEPI for funding
Crumbs I would not worry about the rate op uptake as sure there will be plenty of unvaccinated trial patients to choose from.
In fact current progress may help as Bermuda said we don’t know if part 2 of SA trial will be testing new patients or doing “ boosters” in existing patients
Yep keeping very well flakey and hope you are likewise.
You picked these up at a good time as a rich news period is due.Interesting re the Cobra connection mind you it is only up the road for both of us.
Not sure I do know where you mean as we exchanged a few good local pubs a while back.Please give me a clue as a reminder unless you mean the Brownlow as was there last week
Virtually every post here is their individual opinion and of course we are entitled to freely agree or disagree.If posters agree like I often do with Bermuda it does not mean that it is in collusion or an attempt to curry favour or to have a go at someone we may disagree with.
I will change my views of news changes or someone persuades me otherwise.
So yes like many I was critical of how the CH news was released and thought on Thursday that the SP would be hit yesterday.
Obviously that thought was before the positive RNS regarding start of the SA trial so my earlier view would change.
So yes I was wrong in my assessment of yesterday SP performance and glad as I would rather be wrong and better off but the news picture was altered and then the news changed again with the Diggle buy.
Anyway we all have different levels of tolerance and stress so there are bound to be the odd bout of friction but sure not many take these things so seriously that we ever forget that there are more things that unite us like a rising SP than divide us
Thanks for reasonable response.
Yep agree that it is very hard for small bio pharma to advance the drug development of any assets on its own without “ commercial partners” to Approval but it was purely the point about them being able to advance their assets through the trial process that I wanted to evidence.
Anyway we both know our positions and look forward to another good run next week.
Chester yep the staff number may be higher than 22 and SCLP has recruited a lot of staff which bodes well for entering the next stage in its development.
Personally doubt they will take it into p3 on their own due not only to the high cost but I expect any validation of either SCIB 1 Combo and/ or Modi or Covidity p1 I expect a commercial deal or deals to move us forward
You may have me filtered already so be it but as others have said you do seem pretty aggressive and fine to disagree with any poster.
However when you personally attack a very respected and balanced poster like Bermuda who only seeks to respond when directly asked to comment/ when a post is directly aimed at him/ or to post information in a very neutral way then expect to be challenged and everyone can make their own view.
Particularly on this occasion when it seems clear to me that your insistence that SCLP cannot run a p1 trial and that your talk of “ partnerships” was clearly aimed at commercial partnerships so that a third party would finance/ help with the trials is simply not true.
The “ partnership “ evidence you highlight in the RNS is clearly an academic type arrangement to develop the delivery mechanism etc and not a commercial deal involving any monetisation.
Plus a previous bio you were invested in managed to run two p3 trials with less than 6 employees so I hardly think that SCLP with 22 employees abd have a proven track record of conducting p1/2trials previously with a much smaller team
So if you manage to read this fine if I am not already on the green list or please just put me on it as at least I will be in good Company
Crumbs it literally was Thursday night fight night on ADVFN with 2 folk wanting to fight.
I of course was trying to be Barry Hearn suggesting that the M5/M6 corridor may be a more suitable location than Watford Gap or Leeds which were the suggestions of the protagonists who live in Cornwall and Cumbria lol
Ananda exactly which part of Bermudas post is nonsense.
Let us be absolutely straight here we are very confident in the future agree with Lindy that we have an exciting pipeline and offers limitless potential.
But at this point in time until they get trial data which at the moment apart from SCIB 1 they have no human data whatsoever then comparisons of SCLP to Bion Tech are exactly that comparisons of two entirely different outfits.One is a proven multi billion £ Company that has secured multi million deals with some of the biggest names in pharma.The other SCLP is potentially a $1bn plus Company but as yet has no trial data and no deals.
That can change but at the moment it is pure conjecture.
A Fiat and a Ferrari are both Italian Cars and you may consider that comparable whereas personally I feel until SCLP proves to be a Lamborghini we can get a more comparable example
Ananda if you honestly believe that you are comparing like with like then why do you think Ugr Sahin has not picked up the phone to Lindy like he did with Kathrin Jannsen.
Surely if they are valued the same as you claim then it would be a helluva good value phone call.
The value of the two projects is totally different based largely on the extreme urgency in the Bion Tech case but why let the facts get in the way of a good ramp.
When SCLP comes up with trial data we can all get a more realistic value on the science.That is what SCLP have always stated but why bother with the stated intentions of the Company you are invested in when you can pluck figures out the air
Really decent day and the good news about the SA trial starting has helped sway sentiment from last night where it would still be good to get more clarification on last nights news.
As has been said very bullish quote from LD and absolutely she is best able to comment sagely on the science which we will all know will determine the outcome here.
I do believe SP predictions of multiples of £s whilst possible is meaningless and only serves to heighten expectations on all sides.
I would rather people just rein in some of the wilder predictions until at least we have some actual trial data and try and add a tinge of realism to any perspective valuations as I think some have got a bit excited today and overheated
Miavoce,I am judging her on her time as joint CEO for several years and her skill set I have observed as compared for what that specific CEO role requires.
If she commits to being a full time CEO so she gives up her Uni responsibilities then I will be happy to admit I may have got her wrong but if she adopts it as a part time role and also continues her CSO duties and is not an interim appointment then I feel it sends out totally the wrong message.
Purely my thoughts